Skip to main content
. Author manuscript; available in PMC: 2014 Mar 14.
Published in final edited form as: Prostate. 2010 Sep 1;70(12):1274–1285. doi: 10.1002/pros.21163

Fig. 5.

Fig. 5

AIM-100 inhibits pTyr267-AR binding to AREs. A,C,E: Serum and androgen-depleted LAPC4 cells were treated (or untreated) with DHT (5 nM, 16 hr) or EGF (10 ng/ml, 1 hr), and AIM-100 (0.8 μM, 16 hr) and ChIP analysis for total AR binding to the PSA(A), TMPRSS2 (C), and NKX3.1 (E) AREs was performed followed by quantitative PCR. Data shown are representative of three independent experiments. B,D,F: Serum and androgen-depleted LAPC4 cells were treated with DHT (5 nM, 16 hr) or EGF (10 ng/ml, 1 hr), and AIM-100 (0.8 μM, 16 hr) and ChIP analysis for pTyr267-AR binding to the PSA (B), TMPRSS2 (D) and NKX3.1 (F) AREs was performed followed by quantitative PCR. Data shown are representative of three independent experiments. *P≤ 0.001; **P≤ 0.006; ***P≤0.014.